NF-κB is a well-known transcriptional factor having critical functions in B-cell malignancies; in particular, enhanced proliferation of LCLs and BL cells was found to be dependent on NF-κB signalling as NF-κB inhibition decreased cellular proliferation in both cell types [59,60]. This evidence concerns the gene NFKB1 and Burkitt lymphoma.